Construction and Validation of a Model for Predicting Cervical Intraepithelial Neoplasia Grade II+: A Cross-Sectional Population Study via Machine Learning
Authors:
- Juan HeJHJuan He
- Kang-Jia ChenKCKang-Jia Chen
- Ya-Xing FangYFYa-Xing Fang
- Yu-Feng HeYHYu-Feng He
- Lan XiangLXLan Xiang
- Xue-Mei WangXWXue-Mei Wang
- Ming-Li ZhouMZMing-Li Zhou
- Shu-Guang ZhouSZShu-Guang Zhou
- Jing-Jing HuJHJing-Jing Hu
Open Access
- 1 December 2025
- journal article
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5195-5208
Abstract
Cervical cancer, as the leading malignant tumor among women globally, underscores the critical need for early screening; however, effective models for predicting cervical lesions remain lacking. To construct a predictive model for cervical intraepithelial neoplasia II+(CINII+), and to compare the predictive performance of machine learning models integrating thinprep cytologic test (TCT) + human papillomavirus (HPV) testing with clinical data versus TCT combined with traditional clinical data for CIN II+. Clinical data from women undergoing cervical cancer screening at Linquan Maternity and Child Healthcare Hospital (2020–2024) were collected, including TCT results, HPV status, cervical pathology, age, sexual history and other clinical data. Ten machine learning algorithms were applied to develop two predictive models: Model 1(TCT+HPV+clinical data) and Model 2(TCT+traditional clinical data). Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves and decision curve analysis (DCA). Multivariate logistic regression analysis showed that HPV positivity, TCT indicates High-Grade Squamous Intraepithelial Lesion(HSIL), colposcopy result indicates a high-grade lesion and the first age of pregnancy as predictors of CINII+. Model 1 (TCT+HPV+clinical data) demonstrated significantly higher predictive efficacy than Model 2(TCT+clinical data), the difference in AUC is statistically significant. (P=0.006 in training set; P=0.035 in testing set). The TCT+HPV-integrated model outperformed the TCT-only model in predicting CIN II+, supporting the incorporation of HPV testing into routine screening to enhance early diagnostic accuracy.Keywords
This publication has 33 references indexed in Scilit:
- Establishment and validation of a risk prediction model for high-grade cervical lesionsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2022
- HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulationThe International Journal of Biochemistry & Cell Biology, 2021
- Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triageCancer Medicine, 2021
- HPV‐related methylation‐based reclassification and risk stratification of cervical cancerMolecular Oncology, 2020
- HPV vaccination and cancer preventionBest Practice & Research Clinical Obstetrics & Gynaecology, 2020
- Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plansClinical Microbiology and Infection, 2020
- HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccinePapillomavirus Research, 2019
- Cervical Cancer Screening: Past, Present, and FutureSexual Medicine Reviews, 2019
- The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implicationsCancer Medicine, 2018
- Baseline colposcopic findings in women entering studies on female vaginal productsContraception, 2008